ctrl K

Watchlist Price Alert

Albany Molecular Research... (AMRI)

NASDAQ: AMRI · Real-Time Price · USD

undefined

null (null%)

At close: Jun 28, 2019, 10:07 PM

Albany Molecular Research Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	172.93M	163.82M	191.32M	152.74M	120.81M	105.58M
Cost of Revenue	131.72M	122.78M	152.59M	123.49M	82.21M	79.36M
Gross Profit	41.22M	41.04M	38.74M	29.25M	38.6M	26.22M
Operating Income	-1.55M	2.08M	-5.41M	-15.66M	6.46M	-4.15M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-14.9M	-11.54M	-12.49M	-28.92M	-6.26M	-12.29M
Net Income	-10.24M	-10.69M	-15.41M	-23.43M	-21.27M	-10.07M
Selling & General & Admin	38.65M	33.43M	32.31M	37.3M	27.93M	24.6M
Research & Development	3.46M	3.37M	4.76M	4.64M	3.48M	3.17M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	42.11M	36.8M	37.06M	41.95M	31.4M	27.77M
Interest Expense	12.71M	12.83M	13.01M	12.71M	7.06M	7.14M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	174.49M	161.74M	196.73M	168.4M	114.34M	109.73M
Income Tax Expense	-5.5M	-850K	2.92M	-5.5M	15.01M	-2.22M
Shares Outstanding (Basic)	42.45M	42.45M	42.45M	36.99M	34.83M	34.83M
Shares Outstanding (Diluted)	42.45M	42.45M	42.45M	36.99M	34.83M	34.83M
EPS (Basic)	-0.24	-0.25	-0.36	-0.63	-0.61	-0.29
EPS (Diluted)	-0.24	-0.25	-0.36	-0.63	-0.61	-0.29
EBITDA	16.31M	20.1M	21.78M	1.01M	9.53M	4.34M
EBIT	-2.19M	1.29M	518K	-16.21M	805K	-5.15M
Depreciation & Amortization	19.35M	18.82M	21.27M	17.22M	8.72M	9.49M